By Lillie-Beth Brinkman
Copyright (©) 2015, The Oklahoma Publishing Company
At the BIO Convention, Oklahoma State University’s tech transfer office is pitching several projects from its research scientists for possible commercialization.
Two of them are particularly close to being ready for business partners, said Scott Davis, a licensing associate with OSU’s Technology Development Center.
First, a vaccine for respiratory syncytial virus (RSV) being developed by Tom Oomens in OSU’s Center for Respiratory and Infectious Diseases is nearly finished with animal testing, Davis said. So far, data is showing the vaccine to be safe and effective.
At BIO, Davis has received significant interest from at least one pharmaceutical company for the work being done by Oomens.
Another medical breakthrough for which Davis is seeking collaborators involves the work of food microbiologist Divya Jaroni, an assistant professor of animal science at OSU whose work would help fight certain bacteria that cause food poisoning.
A company has expressed interest in collaborating with her, Davis said.
